Brellium provides an AI platform that helps healthcare providers streamline compliance across millions of patient visits. The platform proactively audits every patient visit, identifying compliance risks before they become problems and notifying clinical teams with clear instructions to correct charts. Clinical teams use Brellium to ensure each patient visit meets payor and clinical quality standards without the manual workload. The company serves customers including Grow Therapy, Rula, Headspace, Hopebridge, Lightfully Behavioral Health and Talkiatry. Led by CEO Zach Rosen, Brellium intends to use the new funding to grow the team and accelerate its product roadmap.

Total raised

$14M

Funding rounds

1

Latest round

Series A

Latest activity

Apr 2025